Clinical Trials Directory

Trials / Unknown

UnknownNCT05952050

Different Administration Routes of Dexmedetomidine on Postoperative Delirium

Effect of Different Administration Routes of Dexmedetomidine on Postoperative Delirium in Elderly Patients Undergoing General Anesthesia

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
120 (estimated)
Sponsor
Boston Intelligent Medical Research Center, Shenzhen United Scheme Technology Co., Ltd. · Industry
Sex
All
Age
65 Years – 99 Years
Healthy volunteers
Accepted

Summary

Intravenous dexmedetomidine has been reported to decrease the occurrence of postoperative delirium (POD) in elderly patients. Nevertheless, some previous studies have indicated that intratracheal dexmedetomidine and intranasal dexmedetomidine are also effective and convenient. The current study aimed to compare the effect of different administration routes of dexmedetomidine on POD in elderly patients.

Conditions

Interventions

TypeNameDescription
DRUGDexmedetomidineDifferent Administration Routes of Dexmedetomidine

Timeline

Start date
2023-08-01
Primary completion
2023-08-01
Completion
2023-09-30
First posted
2023-07-19
Last updated
2023-07-19

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05952050. Inclusion in this directory is not an endorsement.